Basic Information
RNALocate ID: RLID:01001459
RNA Symbol: hsa-miR-103a-3p
Localization: Mitochondrion
RNA Information
RNA Name: hsa-miR-103
RNA ID: miRBase:MIMAT0000101
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 21637849
Tissue/Cell Line: Skeletal muscle myoblasts
Method: ISH|qRT-PCR
Description: List of microRNA significantly detected in the mitochondrial mRNA at three increasing mtRNA inputs (1, 5 and 35 uL). Table S3 List of microRNA significantly detected (Cp<35) in the mitochondrial mRNA at the two highest mtRNA inputs (5 and 35 uL). Data are collected from Table 4 and S3.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001454 Cytoplasm Nasopharyngeal carcinoma cells 20498841
RLID:01001455 Cytoplasm Neural progenitor cells 21363885
RLID:01001456 Cytoplasm Cell line (HeLa) 21695135
RLID:01001457 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001458 Mitochondrion Myotube|Osteosarcoma cell line (143B) 27396686
RLID:01001460 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01001461 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001462 Nucleolus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001463 Nucleus Nasopharyngeal carcinoma cells 20498841
RLID:01001464 Nucleus Colon adenocarcinoma cells 20864815
RLID:11001017 Exosome Human cervical cancer cell line (HeLa) 25760330
RLID:11001018 Exosome Pooled sera 27278097
RLID:11001019 Exosome Serum 18589210
RLID:11001020 Exosome Peripheral blood mononuclear cells 19002258
RLID:11001021 Exosome Breast cancer cell line (MCF-7) 20976003
RLID:11001022 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11001023 Exosome Brain tissue 23382797
RLID:11001024 Exosome Human mast cell line (HMC-1) 24009880
RLID:11001025 Microvesicle Plasma 19002258
RLID:11001026 Microvesicle Plasma 23077538
RLID:11001027 Microvesicle Seminal plasma 23539611
RLID:11001028 Microvesicle Follicular fluid 23666971
RLID-D:11000035 Exosome Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue
RLID-D:11000300 Microvesicle Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-103a-3p Splenic marginal zone lymphoma MNDR-E-MI-02946
MNDR hsa-miR-103a-3p Oral squamous cell carcinoma MNDR-E-MI-02947
MNDR hsa-miR-103a-3p Large cell neuroendocrine cancer MNDR-E-MI-02948
MNDR hsa-miR-103a-3p Medulloblastoma MNDR-E-MI-02949
MNDR hsa-miR-103a-3p High-grade serous ovarian carcinoma MNDR-E-MI-02950
MNDR hsa-miR-103a-3p Ovarian clear cell carcinoma MNDR-E-MI-02951
MNDR hsa-miR-103a-3p Uterine corpus endometrial carcinoma MNDR-E-MI-02952
MNDR hsa-miR-103a-3p Lymphoma MNDR-E-MI-02953
MNDR hsa-miR-103a-3p Lymphoma non-hodgkin MNDR-E-MI-02954
MNDR hsa-miR-103a-3p Estrogen-receptor positive breast cancer MNDR-E-MI-02955
MNDR hsa-miR-103a-3p Estrogen-receptor negative breast cancer MNDR-E-MI-02956
MNDR hsa-miR-103a-3p Progesterone-receptor positive breast cancer MNDR-E-MI-02957
MNDR hsa-miR-103a-3p Progesterone-receptor negative breast cancer MNDR-E-MI-02958
MNDR hsa-miR-103a-3p Her2-receptor positive breast cancer MNDR-E-MI-02959
MNDR hsa-miR-103a-3p Breast cancer luminal MNDR-E-MI-02960
MNDR hsa-miR-103a-3p Anencephaly MNDR-E-MI-02961
MNDR hsa-miR-103a-3p Niemann-pick disease type c MNDR-E-MI-02962
MNDR hsa-miR-103a-3p Neurofibromatosis 1 MNDR-E-MI-02963
MNDR hsa-miR-103a-3p Dermatomyositis MNDR-E-MI-02964
MNDR hsa-miR-103a-3p Prostate cancer MNDR-E-MI-02965
MNDR hsa-miR-103a-3p Gastric cancer MNDR-E-MI-02966
MNDR hsa-miR-103a-3p Gastric lymphoma MNDR-E-MI-02967
MNDR hsa-miR-103a-3p Alzheimer disease MNDR-E-MI-02968
MNDR hsa-miR-103a-3p Intracranial aneurysm MNDR-E-MI-02969
MNDR hsa-miR-103a-3p Bladder cancer MNDR-E-MI-02970
MNDR hsa-miR-103a-3p Esophageal carcinoma MNDR-E-MI-02971
MNDR hsa-miR-103a-3p Dysautonomia familial MNDR-E-MI-02972
MNDR hsa-miR-103a-3p Head and neck cancer MNDR-E-MI-02973
MNDR hsa-miR-103a-3p Malaria MNDR-E-MI-02974
MNDR hsa-miR-103a-3p Leukemia MNDR-E-MI-02975
MNDR hsa-miR-103a-3p Huntington disease MNDR-E-MI-02976
MNDR hsa-miR-103a-3p Chorea MNDR-E-MI-02977
MNDR hsa-miR-103a-3p Cardiovascular disease MNDR-E-MI-02978
MNDR hsa-miR-103a-3p Carotid stenosis MNDR-E-MI-02979
MNDR hsa-miR-103a-3p Moyamoya disease MNDR-E-MI-02980
MNDR hsa-miR-103a-3p Lung cancer MNDR-E-MI-02981
MNDR hsa-miR-103a-3p Endometrial cancer MNDR-E-MI-02982
MNDR hsa-miR-103a-3p Parkinson disease MNDR-E-MI-02983
MNDR hsa-miR-103a-3p Niemann-pick disease MNDR-E-MI-02984
MNDR hsa-miR-103a-3p Basal-like breast cancer MNDR-E-MI-02985
MNDR hsa-miR-103a-3p Thyroid cancer MNDR-E-MI-02986
MNDR hsa-miR-103a-3p Pituitary neoplasms MNDR-E-MI-02987
MNDR hsa-miR-103a-3p Malignant mesothelioma MNDR-E-MI-02988
MNDR hsa-miR-103a-3p Pancreatic cancer MNDR-E-MI-02989
MNDR hsa-miR-103a-3p Melanoma MNDR-E-MI-02990
MNDR hsa-miR-103a-3p Nephroblastoma MNDR-E-MI-02991
MNDR hsa-miR-103a-3p Colon cancer MNDR-E-MI-02992
MNDR hsa-miR-103a-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-02993
MNDR hsa-miR-103a-3p Prostate adenocarcinoma MNDR-E-MI-02994
MNDR hsa-miR-103a-3p Cerebellar disease MNDR-E-MI-02995
MNDR hsa-miR-103a-3p Carcinoma ductal breast MNDR-E-MI-02996
MNDR hsa-miR-103a-3p Glioblastoma MNDR-E-MI-02997
MNDR hsa-miR-103a-3p Glioma MNDR-E-MI-02998
MNDR hsa-miR-103a-3p Chordoma MNDR-E-MI-02999
MNDR hsa-miR-103a-3p Amyotrophic lateral sclerosis MNDR-E-MI-03000
MNDR hsa-miR-103a-3p Epilepsy temporal lobe MNDR-E-MI-03001
MNDR hsa-miR-103a-3p Osteosarcoma MNDR-E-MI-03002
MNDR hsa-miR-103a-3p Inclusion body myositis MNDR-E-MI-03003
MNDR hsa-miR-103a-3p Meningioma MNDR-E-MI-03004
MNDR hsa-miR-103a-3p Liver cancer MNDR-E-MI-03005
MNDR hsa-miR-103a-3p Uterine cancer MNDR-E-MI-03006
MNDR hsa-miR-103a-3p Gastric adenocarcinoma MNDR-E-MI-03007
MNDR hsa-miR-103a-3p Pituitary adenoma MNDR-E-MI-03008
MNDR hsa-miR-103a-3p Lung squamous cell carcinoma MNDR-E-MI-03009
MNDR hsa-miR-103a-3p Carcinoma lung non-small-cell MNDR-E-MI-03010
MNDR hsa-miR-103a-3p Lung adenocarcinoma MNDR-E-MI-03011
MNDR hsa-miR-103a-3p Adrenocortical cancer MNDR-E-MI-03012
MNDR hsa-miR-103a-3p Thyroid carcinoma MNDR-E-MI-03013
MNDR hsa-miR-103a-3p Ovarian carcinoma MNDR-E-MI-03014
MNDR hsa-miR-103a-3p Bladder urothelial carcinoma MNDR-E-MI-03015
MNDR hsa-miR-103a-3p Pancreatic adenocarcinoma MNDR-E-MI-03016
MNDR hsa-miR-103a-3p Carcinoma renal cell MNDR-E-MI-03017
MNDR hsa-miR-103a-3p Kidney renal papillary cell carcinoma MNDR-E-MI-03018
MNDR hsa-miR-103a-3p Renal clear cell carcinoma MNDR-E-MI-03019
MNDR hsa-miR-103a-3p Cholangiocarcinoma MNDR-E-MI-03020
MNDR hsa-miR-103a-3p Esophageal cancer MNDR-E-MI-03021
MNDR hsa-miR-103a-3p Liver cirrhosis MNDR-E-MI-03022
MNDR hsa-miR-103a-3p Lung small cell carcinoma MNDR-E-MI-03023
MNDR hsa-miR-103a-3p Encephalopathy bovine spongiform MNDR-E-MI-03024
MNDR hsa-miR-103a-3p Synovial sarcoma MNDR-E-MI-03025
MNDR hsa-miR-103a-3p Head and neck squamous cell carcinoma MNDR-E-MI-03026
MNDR hsa-miR-103a-3p Growth hormone-secreting pituitary adenoma MNDR-E-MI-03027
MNDR hsa-miR-103a-3p Fibromyalgia MNDR-E-MI-03028
MNDR hsa-miR-103a-3p Encephalomyelitis MNDR-E-MI-03029
MNDR hsa-miR-103a-3p Breast invasive carcinoma MNDR-E-MI-03030
MNDR hsa-miR-103a-3p Hepatocellular carcinoma MNDR-E-MI-03031
MNDR hsa-miR-103a-3p B-cell lymphoma MNDR-E-MI-03032
MNDR hsa-miR-103a-3p Rheumatoid arthritis MNDR-E-MI-03033
MNDR hsa-miR-103a-3p T-cell leukemia MNDR-E-MI-03034
MNDR hsa-miR-103a-3p Retinoblastoma MNDR-E-MI-03035
MNDR hsa-miR-103a-3p Neuroblastoma MNDR-E-MI-03036
MNDR hsa-miR-103a-3p Chronic fatigue syndrome MNDR-E-MI-03037
MNDR hsa-miR-103a-3p Hodgkin lymphoma MNDR-E-MI-03038
MNDR hsa-miR-103a-3p Burkitt lymphoma MNDR-E-MI-03039
MNDR hsa-miR-103a-3p Dementia vascular MNDR-E-MI-03040
MNDR hsa-miR-103a-3p Tonsil cancer MNDR-E-MI-03041
MNDR hsa-miR-103a-3p Acute myeloid leukemia MNDR-E-MI-03042
MNDR hsa-miR-103a-3p Colorectal cancer MNDR-E-MI-03043
MNDR hsa-miR-103a-3p Nasopharynx carcinoma MNDR-E-MI-03044
MNDR hsa-miR-103a-3p Multiple myeloma MNDR-E-MI-03045
MNDR hsa-miR-103a-3p Ovarian epithelial cancer MNDR-E-MI-03046
MNDR hsa-miR-103a-3p Cardiomegaly MNDR-E-MI-03047
MNDR hsa-miR-103a-3p Nasopharyngeal cancer MNDR-E-MI-03048
MNDR hsa-miR-103a-3p Prostatic neoplasms MNDR-E-MI-03049
MNDR hsa-miR-103a-3p Pseudorabies MNDR-E-MI-03050
MNDR hsa-miR-103a-3p Sleep deprivation MNDR-E-MI-03051
MNDR hsa-miR-103a-3p Epstein-barr virus infections MNDR-E-MI-03052
MNDR hsa-miR-103a-3p Cerebral hemorrhage traumatic MNDR-E-MI-03053
MNDR hsa-miR-103a-3p Intracranial hemorrhage hypertensive MNDR-E-MI-03054
MNDR hsa-miR-103a-3p Venous thromboembolism MNDR-E-MI-03055
MNDR hsa-miR-103a-3p Stroke lacunar MNDR-E-MI-03056
MNDR hsa-miR-103a-3p Non-alcoholic fatty liver disease MNDR-E-MI-03057
MNDR hsa-miR-103a-3p Breast cancer her3+ negative MNDR-E-MI-03058
MNDR hsa-miR-103a-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-03059
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter AADAT Homo sapiens RR00020840
TOP